Oscar Health (OSCR) Stock Forecast & Price Target

$14.87 -0.57 (-3.69%)

(As of 11/15/2024 ET)

Oscar Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
1

Hold
2

Buy
5

Based on 8 Wall Street analysts who have issued ratings for Oscar Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a sell rating, 2 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for OSCR.

Consensus Price Target

$22.93
54.19% Upside

According to the 8 analysts' twelve-month price targets for Oscar Health, the average price target is $22.93. The highest price target for OSCR is $28.00, while the lowest price target for OSCR is $13.50. The average price target represents a forecasted upside of 54.19% from the current price of $14.87.

OSCR Analyst Ratings Over Time

Type	Current Forecast 11/17/23 to 11/16/24	1 Month Ago 10/18/23 to 10/17/24	3 Months Ago 8/19/23 to 8/18/24	1 Year Ago 11/17/22 to 11/17/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.93	$24.00	$21.79	$7.70
Forecasted Upside	54.19% Upside	42.86% Upside	16.50% Upside	1.18% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

OSCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OSCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oscar Health Stock vs. The Competition

Type	Oscar Health	Finance Companies	S&P 500
Consensus Rating Score	2.63	2.49	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	54.19% Upside	12.12% Upside	9.87% Upside
News Sentiment Rating	Positive News See Recent OSCR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/6/2024	Bank of America 4 of 5 stars		Downgrade	Neutral ➝ Underperform	$21.00 ➝ $13.50	-26.35%
10/7/2024	UBS Group 4 of 5 stars		Initiated Coverage	Neutral	$23.00	+14.20%
9/10/2024	Piper Sandler 2 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$28.00 ➝ $28.00	+60.73%
6/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$24.00 ➝ $27.00	+34.90%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$28.00	+38.75%
2024 Election Year Stocks: Uncover Hidden Gems! (Ad) In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link.
5/9/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$16.00 ➝ $21.00	+1.20%
3/22/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$20.00	+45.40%
8/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$5.00 ➝ $7.50	+17.55%
8/9/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$7.00 ➝ $8.50	+6.38%
2/14/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform	$3.00 ➝ $6.00	+13.42%
11/16/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$3.00	+0.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:23 PM ET.

OSCR Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Oscar Health is $22.93, with a high forecast of $28.00 and a low forecast of $13.50.
: 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There is currently 1 sell rating, 2 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" OSCR shares.
: According to analysts, Oscar Health's stock has a predicted upside of 54.19% based on their 12-month stock forecasts.
: Over the previous 90 days, Oscar Health's stock had 1 downgrade by analysts.
: Oscar Health has been rated by research analysts at Bank of America, Piper Sandler, and UBS Group in the past 90 days.
: Analysts like Oscar Health more than other "finance" companies. The consensus rating for Oscar Health is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how OSCR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

This page (NYSE:OSCR) was last updated on 11/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oscar Health (OSCR) Stock Forecast & Price Target